NCT02039050View on ClinicalTrials.gov

Evaluation of Long-Acting Muscarinic Antagonists in COPD

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Tiotropium

DRUG

Aclidinium

Trial Locations (1)

DD1 9SY

Asthma and Allergy Research Group, University of Dundee, Dundee

All Listed Sponsors
collaborator

Almirall Limited

UNKNOWN

lead

University of Dundee

OTHER

NCT02039050 - Evaluation of Long-Acting Muscarinic Antagonists in COPD | Biotech Hunter | Biotech Hunter